Name: Marlen All-Flexible Compact Convex Mounting Ring,7/8 Opening,Each,GN-102C
Brand: MARLEN MANUFACTURING & DEVELOPMENT CO.
SKU: 33091-173474
Price: 35.99 USD
Availability: InStock

Marlen All-Flexible Compact Convex Mounting Ring,7/8 Opening,Each,GN-102C - 33091-173474

By MARLEN MANUFACTURING & DEVELOPMENT CO.

$35.99

(79 Reviews)

Model

33091-173474

Store

Health Products For You

Manufacturer

MARLEN MANUFACTURING & DEVELOPMENT CO.

Detail

Marlen All-Flexible Compact Convex Mounting Ring is for persons with fleshier abdomens and short or flush stomas. The 1/4 (6mm) convexity applies slight pressure to the stomal area, allowing the stoma to stay within the mounting ring opening and not retract. It is for the smaller person with a well-positioned stoma.

Category

Ostomy

FDA granted fast track designation to Palisade Bios broad-spectrum serine protease inhibitor, LB1148, for expedited return of bowel function following gastrointestinal surgery, according to a manufacturer release. Based on prior clinical studies, LB1148 (Palisade Bio) may accelerate the time to the return of normal GI function by reducing the formation of abdominal adhesions. Palisade Bio is currently assessing return of GI function, post-operative ileus and intra-abdominal adhesions in patients undergoing elective bowel resection in a phase 2 study. Receiving Fast Track ...

>Read More

PHILADELPHIA -- Interleukin-17 inhibition with bimekizumab yields strong joint and skin effects up to week 52 in patients with active psoriatic arthritis, according to data presented at ACR Convergence 2022. Bimekizumab has demonstrated efficacy and safety up to week 24 in the pivotal phase 3 BE OPTIMAL study and was well-tolerated up to 52 weeks in the phase 2b study in patients with active psoriatic arthritis, Christopher Ritchlin, MD, of the University of Rochester Medical Center, told attendees. The objective of the study was to assess the long-term efficacy and ...

>Read More

WASHINGTON -- A special interest group session at The Liver Meeting focused on challenges in treating patients with hepatitis C virus, as well as disparities in access to care. What really became clear is that the real challenges we have in the field are bringing the excellent treatments we have to the patients who are most in need, Tatyana Kushner, MD, associate professor in the division of liver diseases at the Icahn School of Medicine at Mount Sinai, told Healio in this video exclusive. According to Kushner, Jennifer C. Price, MD, PhD, FACP, a speaker at the session and ...

>Read More

As the number of myopia cases increases globally, implementing effective therapies to slow the progression and provide optimal vision correction is critical. It is imperative to regularly examine pre-myopic children and those at high genetic risk to record baseline axial growth measurements. This will enable the detection of myopic onset as early as possible. The age at which myopia is diagnosed serves as a reliable indicator of how rapidly it will progress. Employing interventions such as orthokeratology can provide the most significant benefit as early as ages 7 and 8 years, when axial ...

>Read More

The FDA is investigating the risk of severe hypocalcemia in patients on dialysis treated with the osteoporosis drug Prolia, according to a drug safety communication. The agency said hospitalizations and death have been reported among patients taking Prolia (denosumab, Amgen Inc.) due to hypocalcemia, according to the drug safety communication. Our review of interim results from an ongoing safety study of Prolia suggests an increased risk of hypocalcemia, or low calcium levels in the blood, in patients with advanced kidney disease, the FDA wrote in the communication. Preliminary ...

>Read More

A novel virtual follow-up program helped manage minor ophthalmic emergencies through virtual visits, according to a study presented at Real World Ophthalmology. Ayush A. Parikh and colleagues conducted a retrospective cross-sectional study to explore the outcomes of a virtual emergency department follow-up clinic at Massachusetts Eye & Ear. Near-term follow-up for minor ophthalmic emergencies is often necessary to assess for clinical improvement after initial emergency department (ED) visits but can impose logistical challenges for patients and ophthalmology practices, the ...

>Read More

Samsung Electronics health care subsidiary NeuroLogica Corp. announced it has received 510(k) clearance from the FDA for its BodyTom 64, a mobile head-to-toe CT scanner that can be used for a variety of health care needs. Were thrilled to build off our expertise and elevate point-of-care imaging with our BodyTom 64, which can transform any room in a hospital into an advanced imaging suite, Jason Koshnitsky, senior director of global sales and marketing at NeuroLogica, said in a press release from the company. NeuroLogica designed the BodyTom 64 to enhance user experience ...

>Read More

Product Details for 33091-173474